Clinical Trial Update: SPECTACL: SPECTroscopic Assessment of Coronary Lipid [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update for SPECTACL assessing coronary lipid via spectroscopy in angina conditions; trial completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Angina Unstable
• Myocardial Infarction

Drugs mentioned

• SPECTACL

Snippet

Sponsor: Infraredx | Conditions: Angina Pectoris, Angina, Unstable | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2009-05-28